The risk of AERD | |||
SNP | OR [95% CI] | P* | Pcorr †|
  rs13301 | 1.16 [0.55–2.41] | 0.699 | 1.000 |
  rs2074261 | 0.99 [0.47–2.09] | 0.975 | 1.000 |
  rs7507755 | 0.78 [0.52–1.17] | 0.226 | 1.000 |
  rs2240299 | 0.78 [0.52–1.16] | 0.220 | 1.000 |
  rs2074265 | 1.24 [0.94–1.61] | 0.123 | 1.000 |
  rs718100 | 1.24 [0.95–1.63] | 0.109 | 1.000 |
  rs4141356 | 1.18 [0.91–1.53] | 0.222 | 1.000 |
  rs2074267 | 0.96 [0.72–1.28] | 0.772 | 1.000 |
% decline of FEV1 | |||
SNP | β (± SE) | P** | Pcorr †|
  rs13301 | 1.08 ± 1.25 | 0.387 | 1.000 |
  rs2074261 | 0.06 ± 1.29 | 0.964 | 1.000 |
  rs7507755 | −0.64 ± 0.69 | 0.353 | 1.000 |
  rs2240299 | −0.65 ± 0.69 | 0.344 | 1.000 |
  rs2074265 | 0.34 ± 0.51 | 0.505 | 1.000 |
  rs718100 | 0.31 ± 0.51 | 0.535 | 1.000 |
  rs4141356 | 0.19 ± 0.49 | 0.702 | 1.000 |
  rs2074267 | 0.12 ± 0.52 | 0.814 | 1.000 |